A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)

VX-522 mRNA therapyOngoingActive not recruitingPhase 1Open NCT05668741 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…